Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Tta-q6 | 910484-28-5 | 100.0% | 405.80 g/mol | C20H15ClF3N3O | 50 MG
Supplier: Medchemexpress LLC HY1038850MG
TTA-Q6 is a selective T-type calcium channel antagonist developed for laboratory research into neurological disease. It shows low-nanomolar potency in depolarized FLIPR assays and sub-micromolar activity in hyperpolarized assays, and is supplied as a high-purity small-molecule research compound for in vitro studies; not for human or veterinary use.
- Selective T-type calcium channel antagonist.
- Potent activity in depolarized FLIPR assay (IC50 14 nM).
- Activity in hyperpolarized FLIPR assay (IC50 590 nM).
- High purity suitable for research (reported 99.97%).
- Supplied as a small research pack for laboratory use.
- Intended for in vitro research only; not for clinical use.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?